Cost of colorectal cancer care: sufficient to inform cancer policy?
Menée dans 33 pays européens, cette étude analyse les coûts directs et indirects associés au cancer colorectal pour l'année 2015 (soins de santé, morbidités, traitements anticancéreux, décès prématurés, incapacité, etc.)
The burden of cancer and the projected increase in cancer incidence, estimated tobe 25% by 2035, is a global policy concern. If no further action is taken, cancer will soon be the number one cause of deathin high-income countries. Therefore, it is encouraging to have comprehensive dataof the economic effect of colorectal cancer across Europe, as reported by RaymondHenderson and colleagues in the The Lancet Gastroenterology & Hepatology, which might help to further shape cancer policy. However, although the authors shouldbe congratulated by this impressive work, readers should also be aware of the limitationsof this study.